Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Teva Pharmaceutical Industries Ltd

+ Add to Watchlist

TEVA:IT

22,240.00 ILs 150.00 0.67%

As of 09:24:38 ET on 02/01/2015.

Snapshot for Teva Pharmaceutical Industries Ltd (TEVA)

Open: 22,300.00 Day's Range: 22,240.00 - 22,360.00 Volume: 180,834
Previous Close: 22,390.00 52wk Range: 15,220.00 - 23,770.00 1-Yr Rtn: +44.82%

Stock Chart for TEVA

No chart data available.
  • TEVA:IT 22,240.00
  • 1D
  • 1M
  • 1Y
22,390.00
Interactive TEVA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TEVA

Current P/E Ratio (ttm) 17.5461
Estimated P/E(12/2014) 11.1849
Relative P/E vs. TA-100 1.1865
Earnings Per Share (USD) (ttm) 3.2300
Est. EPS (USD) (12/2014) 5.0670
Est. PEG Ratio 5.0247
Market Cap (M ILS) 190,408.50
Shares Outstanding (M) 855.00
30 Day Average Volume 364,591
Price/Book (mrq) 2.0452
Price/Sale (ttm) 2.3454
Dividend Indicated Gross Yield 2.17%
Cash Dividend (ILs) 121.0000
Dividend Ex-Date 11/17/2014
5 Year Dividend Growth 15.06%
Next Earnings Announcement 02/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TEVA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TEVA

Teva Pharmaceutical Industries Ltd., is a global pharmaceutical company. The Company develops, manufactures, and markets generic and branded human pharmaceuticals as well as active pharmaceutical ingredients.

Erez VigodmanPresident/CEOItzhak KrinskyChairman:Teva Japan & South Korea
Allan ObermanPresident & CEO:AmericasJudith VardiPresident & CEO:Emia & Asia Pacific
More Company Profile & Key Executives for TEVA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil